Blank check.
On 2/10/2021 the company announced a pending merger with Mount Sinai Genomics, Inc. d/b/a Sema4 an AI-driven patient-centered genomic and clinical data insight platform company founded on the idea that more information, deeper analysis, and increased engagement will improve the diagnosis, treatment, and prevention of disease.
$18.05 -1.71 (-8.63%)
As of 03/03/2021 15:47:55 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.